# Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy

> **NCT01697345** · EARLY_PHASE1 · COMPLETED · sponsor: **Creighton University** · enrollment: 12 (actual)

## Conditions studied

- Breast Cancer
- Vaginal Dryness
- Dyspareunia
- Sexual Health Quality of Life

## Interventions

- **DRUG:** Testosterone

## Key facts

- **NCT ID:** NCT01697345
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697345, "Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01697345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*